Bacterial antimicrobial resistance and dermatological ramifications.
Br J Dermatol
; 187(1): 12-20, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-1788834
ABSTRACT
The spread of COVID-19 serves as a reminder of the might of microbes in the era of modern medicine. For years, another threat has preoccupied infectious disease experts and public health officials alike rising antimicrobial resistance (AMR). Resistance is exceeding stewardship efforts as well as the rates of new drug development and approval in the market. A dry antimicrobial pipeline is threatening regression to a preantibiotic era. While the consequences of resistance may seem far removed from daily clinical practice, awareness of AMR is essential to dermatological care given that dermatologists prescribe more antibiotics per physician than other providers. Antibiotics in dermatology are often used for prolonged courses, with significant potential for microbiome alteration and antibiotic-related adverse effects. Through this review we hope to contribute to efforts of bringing the crisis of AMR to the forefront of daily dermatological practice.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Bacterial Infections
/
COVID-19
/
Anti-Infective Agents
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Br J Dermatol
Year:
2022
Document Type:
Article
Affiliation country:
Bjd.21033
Similar
MEDLINE
...
LILACS
LIS